Michail E. Klontzas

Lidia Garrucho, Smriti Joshi, Kaisar Kushibar et al.

Breast cancer is the most frequently diagnosed malignancy among women worldwide and a leading cause of cancer-related mortality. Dynamic contrast-enhanced magnetic resonance imaging plays a central role in tumor characterization and treatment monitoring, particularly in patients receiving neoadjuvant chemotherapy. However, existing artificial intelligence models for breast magnetic resonance imaging are often developed using single-center data and evaluated using aggregate performance metrics, limiting their generalizability and obscuring potential performance disparities across demographic subgroups. The MAMA-MIA Challenge was designed to address these limitations by introducing a large-scale benchmark that jointly evaluates primary tumor segmentation and prediction of pathologic complete response using pre-treatment magnetic resonance imaging only. The training cohort comprised 1,506 patients from multiple institutions in the United States, while evaluation was conducted on an external test set of 574 patients from three independent European centers to assess cross-continental and cross-institutional generalization. A unified scoring framework combined predictive performance with subgroup consistency across age, menopausal status, and breast density. Twenty-six international teams participated in the final evaluation phase. Results demonstrate substantial performance variability under external testing and reveal trade-offs between overall accuracy and subgroup fairness. The challenge provides standardized datasets, evaluation protocols, and public resources to promote the development of robust and equitable artificial intelligence systems for breast cancer imaging.

Eleftherios Tzanis, Michail E. Klontzas

Agentic systems built on large language models (LLMs) offer promising capabilities for automating complex workflows in healthcare AI. We introduce mAIstro, an open-source, autonomous multi-agentic framework for end-to-end development and deployment of medical AI models. The system orchestrates exploratory data analysis, radiomic feature extraction, image segmentation, classification, and regression through a natural language interface, requiring no coding from the user. Built on a modular architecture, mAIstro supports both open- and closed-source LLMs, and was evaluated using a large and diverse set of prompts across 16 open-source datasets, covering a wide range of imaging modalities, anatomical regions, and data types. The agents successfully executed all tasks, producing interpretable outputs and validated models. This work presents the first agentic framework capable of unifying data analysis, AI model development, and inference across varied healthcare applications, offering a reproducible and extensible foundation for clinical and research AI integration. The code is available at: https://github.com/eltzanis/mAIstro

Eleftherios Tzanis, Michail E. Klontzas, Antonios Tzortzakakis

Purpose: To develop and evaluate DosimeTron, an agentic AI system for automated patient-specific MC internal radiation dosimetry in PET/CT examinations. Materials and Methods: In this retrospective study, DosimeTron was evaluated on a publicly available PSMA-PET/CT dataset comprising 597 studies from 378 male patients acquired on three scanner models (18-F, n = 369; 68-Ga, n = 228). The system uses GPT-5.2 as its reasoning engine and 23 tools exposed via four Model Context Protocol servers, automating DICOM metadata extraction, image preprocessing, MC simulation, organ segmentation, and dosimetric reporting through natural-language interaction. Agentic performance was assessed using diverse prompt templates spanning single-turn instructions of varying specificity and multi-turn conversational exchanges, monitored via OpenTelemetry traces. Dosimetric accuracy was validated against OpenDose3D across 114 cases and 22 organs using Pearson's r, Lin's concordance correlation coefficient (CCC), and Bland-Altman analysis. Results: Across all prompt templates and all runs, no execution failures, pipeline errors, or hallucinated outputs were observed. Pearson's r ranged from 0.965 to 1.000 (median 0.997; all p < 0.001) and CCC from 0.963 to 1.000 (median 0.996). Mean absolute percentage difference was below 5% for 19 of 22 organs (median 2.5%). Total per-study processing time (SD) was 32.3 (6.0) minutes. Conclusion: DosimeTron autonomously executed complex dosimetry pipelines across diverse prompt configurations and achieved high dosimetric agreement with OpenDose3D at clinically acceptable processing times, demonstrating the feasibility of agentic AI for patient-specific Monte Carlo dosimetry in PET/CT.

Konstantinos Vrettos, Galini Papadaki, Emmanouil Brilakis et al.

The rapid developments in artificial intelligence (AI) research in radiology have produced numerous models that are scattered across various platforms and sources, limiting discoverability, reproducibility and clinical translation. Herein, OpenRad was created, a curated, standardized, open-access repository that aggregates radiology AI models and providing details such as the availability of pretrained weights and interactive applications. Retrospective analysis of peer reviewed literature and preprints indexed in PubMed, arXiv and Scopus was performed until Dec 2025 (n = 5239 records). Model records were generated using a locally hosted LLM (gpt-oss:120b), based on the RSNA AI Roadmap JSON schema, and manually verified by ten expert reviewers. Stability of LLM outputs was assessed on 225 randomly selected papers using text similarity metrics. A total of 1694 articles were included after review. Included models span all imaging modalities (CT, MRI, X-ray, US) and radiology subspecialties. Automated extraction demonstrated high stability for structured fields (Levenshtein ratio > 90%), with 78.5% of record edits being characterized as minor during expert review. Statistical analysis of the repository revealed CNN and transformer architectures as dominant, while MRI was the most commonly used modality (in 621 neuroradiology AI models). Research output was mostly concentrated in China and the United States. The OpenRad web interface enables model discovery via keyword search and filters for modality, subspecialty, intended use, verification status and demo availability, alongside live statistics. The community can contribute new models through a dedicated portal. OpenRad contains approx. 1700 open access, curated radiology AI models with standardized metadata, supplemented with analysis of code repositories, thereby creating a comprehensive, searchable resource for the radiology community.

Giulia Romoli, Alessia Capoccia, Filippo Ruffini et al.

Medical image-to-image (I2I) translation enables virtual scanning, i.e. the synthesis of a target imaging modality from a source one without additional acquisitions. Despite growing interest, most proposed methods operate on 2D slices, are evaluated on isolated tasks with different experimental set-ups and lack clinical validation. The primary contribution of this work is a reproducible, standardized comparative evaluation of 3D I2I translation methods in oncological imaging, designed to standardize preprocessing, splitting, inference, and multi-level evaluation across heterogeneous clinical tasks. Within this framework, we compare seven generative models, three Generative Adversarial Networks (GANs: Pix2Pix, CycleGAN, SRGAN) and four latent generative models (Latent Diffusion Model, Latent Diffusion Model+ControlNet, Brownian Bridge, Flow Matching), across eleven datasets spanning three anatomical regions (head/neck, lung, pelvis) and four translation directions (cone-beam CT to CT, MRI to CT, CT to PET, MRI T2-weighted to T2-FLAIR), for a total of 77 experiments under uniform training, inference, and evaluation conditions. The results show that GANs outperform latent generative models across all tasks, with SRGAN achieving statistically significant superiority. Our lesion-level analysis reveals that all models struggle with small lesions and that, in CT to PET synthesis, models reproduce lesion shape more reliably than absolute uptake-related intensity. We also performed a Visual Turing test administered to 17 physicians, including 15 radiologists, which shows near-chance classification accuracy (56.7%), confirming that synthetic volumes are largely indistinguishable from real acquisitions, while exposing a dissociation between quantitative metrics and clinical preference.

Konstantinos Vrettos, Michail E. Klontzas

Background The increasing adoption of Artificial Intelligence (AI) in healthcare has sparked growing concerns about its environmental and ethical implications. Commercial Large Language Models (LLMs), such as ChatGPT and DeepSeek, require substantial resources, while the utilization of these systems for medical purposes raises critical issues regarding patient privacy and safety. Methods We developed a customizable Retrieval-Augmented Generation (RAG) framework for medical tasks, which monitors its energy usage and CO2 emissions. This system was then used to create RAGs based on various open-source LLMs. The tested models included both general purpose models like llama3.1:8b and medgemma-4b-it, which is medical-domain specific. The best RAGs performance and energy consumption was compared to DeepSeekV3-R1 and OpenAIs o4-mini model. A dataset of medical questions was used for the evaluation. Results Custom RAG models outperformed commercial models in accuracy and energy consumption. The RAG model built on llama3.1:8B achieved the highest accuracy (58.5%) and was significantly better than other models, including o4-mini and DeepSeekV3-R1. The llama3.1-RAG also exhibited the lowest energy consumption and CO2 footprint among all models, with a Performance per kWh of 0.52 and a total CO2 emission of 473g. Compared to o4-mini, the llama3.1-RAG achieved 2.7x times more accuracy points per kWh and 172% less electricity usage while maintaining higher accuracy. Conclusion Our study demonstrates that local LLMs can be leveraged to develop RAGs that outperform commercial, online LLMs in medical tasks, while having a smaller environmental impact. Our modular framework promotes sustainable AI development, reducing electricity usage and aligning with the UNs Sustainable Development Goals.

Eleftherios Tzanis, Michail E. Klontzas

Ensuring the long-term reliability of AI models in clinical practice requires continuous performance monitoring and corrective actions when degradation occurs. Addressing this need, this manuscript presents ReclAIm, a multi-agent framework capable of autonomously monitoring, evaluating, and fine-tuning medical image classification models. The system, built on a large language model core, operates entirely through natural language interaction, eliminating the need for programming expertise. ReclAIm successfully trains, evaluates, and maintains consistent performance of models across MRI, CT, and X-ray datasets. Once ReclAIm detects significant performance degradation, it autonomously executes state-of-the-art fine-tuning procedures that substantially reduce the performance gap. In cases with performance drops of up to -41.1% (MRI InceptionV3), ReclAIm managed to readjust performance metrics within 1.5% of the initial model results. ReclAIm enables automated, continuous maintenance of medical imaging AI models in a user-friendly and adaptable manner that facilitates broader adoption in both research and clinical environments.

Lidia Garrucho, Kaisar Kushibar, Claire-Anne Reidel et al.

Artificial Intelligence (AI) research in breast cancer Magnetic Resonance Imaging (MRI) faces challenges due to limited expert-labeled segmentations. To address this, we present a multicenter dataset of 1506 pre-treatment T1-weighted dynamic contrast-enhanced MRI cases, including expert annotations of primary tumors and non-mass-enhanced regions. The dataset integrates imaging data from four collections in The Cancer Imaging Archive (TCIA), where only 163 cases with expert segmentations were initially available. To facilitate the annotation process, a deep learning model was trained to produce preliminary segmentations for the remaining cases. These were subsequently corrected and verified by 16 breast cancer experts (averaging 9 years of experience), creating a fully annotated dataset. Additionally, the dataset includes 49 harmonized clinical and demographic variables, as well as pre-trained weights for a baseline nnU-Net model trained on the annotated data. This resource addresses a critical gap in publicly available breast cancer datasets, enabling the development, validation, and benchmarking of advanced deep learning models, thus driving progress in breast cancer diagnostics, treatment response prediction, and personalized care.